OBJECTIVE: To assess the association between the use of multivitamins and prostate cancer mortality. METHODS: A total of 5585 deaths from prostate cancer were identified during 18 years of follow-up of 475,726 men who were cancer-free and provided complete information on multivitamin use at enrollment in the Cancer Prevention Study II (CPS-II) cohort in 1982. Cox proportional hazards modeling was used to measure the association between multivitamin use at baseline and death from prostate cancer and to adjust for potential confounders. RESULTS: The death rate from prostate cancer was marginally higher among men who took multivitamins regularly (> or =15 times/month) compared to non-users (multivariate rate ratio=1.07, 95% CI: 0.99-1.15); this risk was statistically significant only for those multivitamin users who used no additional (vitamin A, C, or E) supplements (multivariate rate ratio=1.15, 95% CI: 1.05-1.26). In addition, risk was greatest during the initial four years of follow-up (1982-1986, multivariate rate ratio=1.12, 95 CI: 0.87-1.46). CONCLUSIONS: Regular multivitamin use was associated with a small increase in prostate cancer death rates in our study, and this association was limited to a subgroup of users.
OBJECTIVE: To assess the association between the use of multivitamins and prostate cancer mortality. METHODS: A total of 5585 deaths from prostate cancer were identified during 18 years of follow-up of 475,726 men who were cancer-free and provided complete information on multivitamin use at enrollment in the Cancer Prevention Study II (CPS-II) cohort in 1982. Cox proportional hazards modeling was used to measure the association between multivitamin use at baseline and death from prostate cancer and to adjust for potential confounders. RESULTS: The death rate from prostate cancer was marginally higher among men who took multivitamins regularly (> or =15 times/month) compared to non-users (multivariate rate ratio=1.07, 95% CI: 0.99-1.15); this risk was statistically significant only for those multivitamin users who used no additional (vitamin A, C, or E) supplements (multivariate rate ratio=1.15, 95% CI: 1.05-1.26). In addition, risk was greatest during the initial four years of follow-up (1982-1986, multivariate rate ratio=1.12, 95 CI: 0.87-1.46). CONCLUSIONS: Regular multivitamin use was associated with a small increase in prostate cancer death rates in our study, and this association was limited to a subgroup of users.
Authors: J Michael Gaziano; Howard D Sesso; William G Christen; Vadim Bubes; Joanne P Smith; Jean MacFadyen; Miriam Schvartz; JoAnn E Manson; Robert J Glynn; Julie E Buring Journal: JAMA Date: 2012-11-14 Impact factor: 56.272
Authors: Song-Yi Park; Suzanne P Murphy; Lynne R Wilkens; Brian E Henderson; Laurence N Kolonel Journal: Am J Epidemiol Date: 2011-02-22 Impact factor: 4.897
Authors: Kjell M Russnes; Kathryn M Wilson; Mara M Epstein; Julie L Kasperzyk; Meir J Stampfer; Stacey A Kenfield; Sigbjørn Smeland; Rune Blomhoff; Edward L Giovannucci; Walter C Willett; Lorelei A Mucci Journal: Int J Cancer Date: 2013-11-11 Impact factor: 7.396
Authors: Marian L Neuhouser; Matt J Barnett; Alan R Kristal; Christine B Ambrosone; Irena B King; Mark Thornquist; Gary G Goodman Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-08 Impact factor: 4.254
Authors: Yuqing Zhang; Patricia Coogan; Julie R Palmer; Brian L Strom; Lynn Rosenberg Journal: Cancer Causes Control Date: 2008-12-18 Impact factor: 2.506